OncoLens, an Atlanta, GA-based provider of tumor board and cancer treatment planning software solutions, raised $2.5m in Pre-Series A funding.

The round was led by BIP Capital, with participation from Atlanta Technology Angels, and the Robbins Fund.

The company intends to use the funds to expand the capabilities of its solutions and grow its sales and marketing resources.

The company utilizes proprietary algorithms to decrease the workload around multidisciplinary case discussions by bringing together clinical, radiological, and pathological data required for collaboration.

It automatically matches the patient with relevant clinical trials and potential targeted therapies while also providing quality improvement considerations for the care team. | To read full story, visit https://startuparound.com/read/1578339008.8134403/OncoLens-Secures-$2.5M-in-Pre-Series-A-Funding?ref=audio_experience